Orchid Pharma Q4 Results

  • BSE: 524372
  • NSE: ORCHPHARMA
  • ISIN: INE191A01027
  • Sector: Biotechnology & Drugs
BSE
1,508.2549.15 (3.37%)
Volume16.46 K
Updated: Mon 25 Nov, 2024 | 15:55:26
NSE
1,510.5552.20 (3.58%)
Volume96.54 K
Updated: Mon 25 Nov, 2024 | 15:29:57
Today: 1,449.85
1,522.40
52-Wk: 529.95
1,591.55

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Orchid Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 217.10159.76-%209.90-%
    Selling/ General/ Admin Expenses Total 17.5716.68-%16.36-%
    Depreciation/ Amortization 8.428.18-%7.21-%
    Other Operating Expenses Total 42.4933.82-%34.95-%
    Total Operating Expense 196.60154.28-%138.22-%
    Operating Income 20.505.48-%71.69-%
    Net Income Before Taxes 30.386.73-%65.93-%
    Net Income 32.967.59-%59.14-%
    Diluted Normalized EPS 6.811.86-%6.55-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts